About Us

About CPMC

With the rapid pace of scientific discovery, there is a continuing need to identify and fill gaps in the knowledge about, access to, and appropriate use of the latest oncology precision medicine tools.

While individual oncology patient advocacy and provider organizations are prioritizing development of resources, tools, and programs to support their core constituencies in taking maximum advantage of the promise of precision medicine, CPMC provides a forum for information and resource sharing among these groups, to allow for collective efforts and synergistic progress.

Launched in 2021 to build upon the collaboration sparked by the successful activities of the Consistent Testing Terminology Working Group, the CPMC initiative provides an opportunity for multi-stakeholder organization leaders to share information and resources aimed at advancing precision medicine for oncology patients, while identifying and collectively exploring opportunities for multi-stakeholder, cross-tumor collaborations that could engage activities through potential work groups.

The group convenes quarterly on an annual basis with workgroups that meet throughout the year.

Our Priorities

Overarching priorities for CPMC members include:

Enhancing education and awareness of biomarker testing and genetic testing for inherited cancer risk.
Supporting healthcare providers in community settings, including ensuring physicians have tools to interpret test results.
Collecting/collating data to support testing recommendations.
Reducing the complexity of testing reports.
Implementing consistent testing terminology.
Advance policy efforts to support access to testing, including addressing gaps in coverage and reimbursement.